Ayala Pharmaceuticals $20 million at-the-market offering
We advised the sales agent on the stock offering
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Oak Street Health $747.2 million secondary offering
We advised the joint book-running managers on the equity offering
Esco Lifesciences $200 million Series A financing
We are advising Esco Lifesciences on its Series A financing
Fresenius Medical Care $1.5 billion notes offering
We advised the initial purchasers on the Rule 144A / Regulation S notes offering
Accuray private exchange offers
We advised Accuray on its exchange of convertible senior notes
ImmunityBio $500 million at-the-market offering
We advised the sales agent in connection with the equity offering
Vaccitech $110.5 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Aveanna $458.8 million IPO
We advised the underwriters on the IPO and Nasdaq listing
Privia Health $525.8 million IPO
We advised Privia Health on its IPO and Nasdaq listing
Roivant Sciences combination with Montes Archimedes Acquisition
We are advising Roivant Sciences on its combination with a SPAC